Wall Street Zen Downgrades Rocket One Inc. Common Stock (NASDAQ:RKTO) to Strong Sell

Rocket One Inc. Common Stock (NASDAQ:RKTO) was downgraded by Wall Street Zen from a “sell” rating to a “strong sell” rating in a research note issued on Saturday.

RKTO has been the topic of several other reports. D. Boral Capital reissued a “buy” rating and set a $5.00 price objective on shares of Rocket One Inc. Common Stock in a research note on Wednesday, March 25th. Weiss Ratings raised Rocket One Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, June 23rd. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, Rocket One Inc. Common Stock presently has an average rating of “Hold” and an average price target of $5.00.

Rocket One Inc. Common Stock Stock Down 4.1%

Shares of NASDAQ:RKTO opened at $0.81 on Friday. The firm has a fifty day simple moving average of $1.04 and a two-hundred day simple moving average of $0.95. Rocket One Inc. Common Stock has a 52 week low of $0.49 and a 52 week high of $2.45. The stock has a market capitalization of $18.11 million, a P/E ratio of -1.01 and a beta of 0.93.

Rocket One Inc. Common Stock (NASDAQ:RKTO) last announced its earnings results on Friday, May 15th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.03).

Institutional Trading of Rocket One Inc. Common Stock

Institutional investors have recently added to or reduced their stakes in the company. Lido Advisors LLC purchased a new position in shares of Rocket One Inc. Common Stock during the third quarter valued at approximately $32,000. Kestra Private Wealth Services LLC purchased a new stake in shares of Rocket One Inc. Common Stock in the third quarter worth approximately $51,000. Virtu Financial LLC purchased a new stake in shares of Rocket One Inc. Common Stock in the third quarter worth approximately $184,000. Geode Capital Management LLC lifted its stake in shares of Rocket One Inc. Common Stock by 8.0% during the 2nd quarter. Geode Capital Management LLC now owns 122,575 shares of the company’s stock worth $143,000 after acquiring an additional 9,071 shares during the last quarter. Finally, Citadel Advisors LLC bought a new stake in shares of Rocket One Inc. Common Stock during the 3rd quarter worth approximately $232,000. Institutional investors own 7.08% of the company’s stock.

Rocket One Inc. Common Stock Company Profile

Hoth Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the acquisition, licensing and development of novel therapies for dermatological, central nervous system and other debilitating conditions. The company’s strategy emphasizes in-licensing late preclinical or early clinical assets with promising pharmacological profiles and leveraging formulation science to optimize delivery. Core to its approach is the design of topical and localized administration platforms intended to enhance drug penetration, sustain release and reduce systemic exposure.

Hoth’s development pipeline encompasses multiple candidate programs addressing high-unmet-need areas such as atopic dermatitis, epidermolysis bullosa and oral mucositis.